Ketamine Providers in New York
275 providers across 28 cities
New York has 275 ketamine therapy providers across 28 cities. The most common provider types are ketamine infusion clinic, psychiatry practice, mental health practice. Providers in New York commonly treat depression, anxiety, ptsd. Top cities include New York, Brooklyn, White Plains, Astoria, Great Neck.
Ketamine Therapy in New York
New York offers extensive access to ketamine therapy, with 66 providers across the state delivering IV infusions, intramuscular injections, and FDA-approved Spravato treatments. From Manhattan's specialized clinics to upstate practices, New Yorkers seeking relief from treatment-resistant depression, chronic pain, PTSD, and anxiety have growing options. The state's 2025 telehealth regulations and Medicaid coverage of Spravato are expanding access, though significant gaps remain in rural counties designated as mental health shortage areas.
New York ranks 1st nationally with 275 ketamine therapy providers, averaging 9.8 providers per city. The largest provider category is ketamine infusion clinic (42.5% of providers). New York leads the state with 227 providers. 7 providers offer telehealth services.
State Regulations
New York classifies ketamine as a Schedule III controlled substance under Article 33 of the NYS Controlled Substances Act. Only licensed physicians, nurse practitioners, and physician assistants with DEA registration may prescribe or administer it. The state permits off-label clinical use but requires practitioners to consult the Prescription Monitoring Program (PMP) Registry before prescribing. New York has strict inventory and recordkeeping requirements under Part 80 of the state health regulations.
Insurance & Medicaid Coverage
New York Medicaid covers Spravato (esketamine) nasal spray for treatment-resistant depression, but prior authorization is required. Patients must demonstrate failure of at least two oral antidepressants before approval. Managed care plans also cover Spravato with PA, and the approval process typically takes one to three weeks depending on the insurer.
Telehealth Options
In May 2025, the New York Department of Health adopted new regulations permitting controlled substance prescribing via telehealth when consistent with state and federal laws. Practitioners must consult the PMP Registry and use electronic prescribing. Federal telemedicine flexibilities for controlled substances have been extended through December 31, 2026.
Cost of Ketamine Therapy
IV ketamine infusions in New York typically cost $500–$750 per session. New York City clinics are among the most expensive nationally, with prices 20-40% higher than upstate providers. Westchester and Long Island fall between NYC and rural pricing. A standard initial series of 6 infusions runs $3000–$4500. Spravato (esketamine) may be partially or fully covered by insurance.
Mental Health Access
Thirty-nine New York counties are fully designated Mental Health Professional Shortage Areas, predominantly in rural regions. An additional 12 counties hold partial shortage designations. Rural counties average just 6.9 mental health practitioners per 10,000 people — less than half the state ratio. New York has approximately 0.33 ketamine providers per 100,000 residents.
Frequently Asked Questions
- Yes, ketamine therapy is legal in New York when administered by a licensed, DEA-registered practitioner in a clinical setting. Ketamine is a Schedule III controlled substance, so providers must follow strict state recordkeeping and prescription monitoring requirements. Off-label use for depression and pain is permitted, and Spravato (esketamine) is FDA-approved for treatment-resistant depression.
- IV ketamine infusions in New York typically cost $500 to $750 per session, with NYC clinics at the higher end. A standard six-infusion series ranges from $3,000 to $4,500. Spravato may be covered by insurance with copays of $50 to $400 per session. Most IV ketamine clinics are cash-pay only and offer package discounts.
- New York Medicaid covers FDA-approved Spravato (esketamine) nasal spray for treatment-resistant depression with prior authorization. Patients must have tried at least two oral antidepressants first. Standard IV ketamine infusions are generally not covered by Medicaid or most insurance plans, as IV ketamine remains an off-label treatment.